Amoxicillin And Clavulanate Potassium Powder, For Suspension
Product Images NDC 50090-3309

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Amoxicillin And Clavulanate Potassium (NDC 50090-3309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amoxicillin Chemical Structure (Amoxiclav Str1)

Chemical structure diagram of Amoxicillin and Clavulanate Potassium, illustrating the molecular layout with atoms and bonds including functional groups and a water of crystallization (3H2O) notation.*

FDA Label Image

Clavulanic Acid Chemical Structure (Amoxiclav Str2)

Chemical structure of Amoxicillin and Clavulanate Potassium showing the molecular framework, including a beta-lactam ring and associated functional groups, as represented in the product's structural diagram.*

FDA Label Image

Label Image (Lbl500903309)

Amoxicillin and Clavulanate Potassium 400 mg/57 mg per 5 mL powder for suspension in a foiled packet. The label includes storage and reconstitution instructions, with a package size of 180 mL oral suspension when reconstituted. The product is manufactured by A-S Medication Solutions and has NDC 50090-3309.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.